Eden Health GLP-1
From $129/mo · 9.4/10
FDA-approved · 2022
Generic: Tirzepatide · Manufactured by Eli Lilly
First dual GLP-1/GIP receptor agonist. Approved for type 2 diabetes, used off-label for weight loss. Generally shows greater weight loss than semaglutide alone.
Avg weight loss
15-22% of body weight
Monthly price
$1,023
With insurance
$25-$200/month with Lilly savings card
Approved
2022
The 5 top-rated providers we’ve reviewed that prescribe Tirzepatide.
From $129/mo · 9.4/10
From $179/mo · 9.3/10
From $146/mo · 9.2/10
From $199/mo · 9.1/10
From $130/mo · 9.0/10